MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Strona główna・Stock List・Geron Corp

Geron Corp

Closed

SectorHealthcare

1.27 -2.31

Buy Sell

Overview

Share price change

24h

Current

Min

1.26

Max

1.33

Key metrics
By Trading Economics
Income	3.5M -16M
Sales	9.4M 49M
Profit margin	-33.394
Employees	229
EBITDA	9.2M -7.6M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+135.11% upside

Dividends
By Dow Jones
Next Earnings	6 lis 2025

Market Stats
By TradingEconomics
Market Cap	46M 817M
Previous open	3.58
Previous close	1.27

News Sentiment

By Acuity

15%

85%

19 / 371 Ranking in Healthcare

Geron Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 paź 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13 paź 2025, 21:07 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13 paź 2025, 17:03 UTC

Major Market Movers

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13 paź 2025, 23:53 UTC

Market Talk

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13 paź 2025, 23:39 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13 paź 2025, 22:15 UTC

Market Talk

Global Equities Roundup: Market Talk

13 paź 2025, 22:15 UTC

Market Talk

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13 paź 2025, 21:57 UTC

Acquisitions, Mergers, Takeovers

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 paź 2025, 21:36 UTC

Market Talk

Global Equities Roundup: Market Talk

13 paź 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

13 paź 2025, 21:36 UTC

Market Talk

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13 paź 2025, 21:30 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13 paź 2025, 21:06 UTC

Acquisitions, Mergers, Takeovers

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 paź 2025, 20:52 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13 paź 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

13 paź 2025, 20:35 UTC

Acquisitions, Mergers, Takeovers

Goldman Expects to Close Deal in 1Q

13 paź 2025, 20:34 UTC

Acquisitions, Mergers, Takeovers

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13 paź 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Industry Ventures Currently Manages $7B of Assets Under Supervision

13 paź 2025, 20:32 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13 paź 2025, 20:31 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13 paź 2025, 20:29 UTC

Acquisitions, Mergers, Takeovers

Goldman Sachs to Buy VC Firm Industry Ventures

13 paź 2025, 19:05 UTC

Market Talk

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13 paź 2025, 18:59 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13 paź 2025, 18:26 UTC

Market Talk

Precious Metals Close at New Record Highs -- Market Talk

13 paź 2025, 18:10 UTC

Market Talk

Global Equities Roundup: Market Talk

13 paź 2025, 18:10 UTC

Market Talk

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13 paź 2025, 17:05 UTC

Market Talk

Global Equities Roundup: Market Talk

13 paź 2025, 17:05 UTC

Market Talk

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13 paź 2025, 16:03 UTC

Acquisitions, Mergers, Takeovers

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13 paź 2025, 15:35 UTC

Market Talk

Precious Metals Push Record Highs Further -- Market Talk

Peer Comparison

Price change

Geron Corp Forecast

Price Target

By TipRanks

135.11% upside

12 Months Forecast

Average 3.08 USD 135.11%

High 5 USD

Low 1 USD

Based on 7 Wall Street analysts offering 12 month price targets forGeron Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

Buy

Hold

Sell

Based on 7 analysts giving stock ratings to Geron Corp - Dist in the past 3 months.

Sentiment

By Acuity

19 / 371 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.